[ decrease in blood pressure after parenteral trial doses of reserpine ( serpasil ) , hydralazine ( apresolin ) , and pentapyrrolidin ( ansolysen ) in patients with arterial hypertension , with special reference to the value of the test as an indicator of the clinical effect in subsequent peroral prolonged treatment ] .
C0035179
reserpine
C0020538
arterial hypertension